RXFP1 and neoplasm: The activation of the G protein‐coupled relaxin family peptide receptor 1 (RXFP1) promotes tumor growth, angiogenesis, migration, and tissue invasion in several human tumor types, including breast, thyroid, prostate, endometrium, and brain cancer [43, 44, 45, 46, 47, 48].